---
schema_version: "secwatch.filing_event.v1"
accession: "0000883984-22-000020"
form_type: "8-K/A"
ticker: "ICUI"
cik: "0000883984"
company_name: "ICU MEDICAL INC/DE"
filed_at: "2022-03-21T23:59:59+00:00"
generated_at: "2026-06-26T21:34:14.087530+00:00"
event_type: "m_and_a"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# ICU Medical files Smiths Medical FY2021 audited financials; operating profit down 88% to $16M

## Summary
- Smiths Medical revenue $1,153M in FY2021, flat vs $1,159M prior year.
- Operating profit fell to $16M from $129M; includes $83M impairment charge.
- Net profit $66M vs $173M prior year; net assets $1,719M.
- Acquisition closed Jan 6, 2022 for $1.9B cash, 2.5M ICU shares, and up to $100M earn-out.

## SEC filing metadata
- accession: 0000883984-22-000020
- form_type: 8-K/A
- ticker: ICUI
- cik: 0000883984
- company_name: ICU MEDICAL INC/DE
- filed_at: 2022-03-21T23:59:59+00:00
- event_type: m_and_a
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883984/000088398422000020/0000883984-22-000020-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883984/000088398422000020/icui-20220107.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000883984-22-000020
- JSON: https://secwatch.observer/filing/0000883984-22-000020.json
- Plain text: https://secwatch.observer/filing/0000883984-22-000020.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.